%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png)
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于提前赎回药石转债的第十五次提示性公告 | 2025-09-04 | Chinese | |
| 关于提前赎回药石转债的第十四次提示性公告 | 2025-09-03 | Chinese | |
| 关于提前赎回药石转债的第十三次提示性公告 | 2025-09-02 | Chinese | |
| 关于提前赎回药石转债的第十二次提示性公告 | 2025-09-01 | Chinese | |
| 关于药石转债转股数额累计达到转股前公司已发行股份总额10%的公告 | 2025-08-29 | Chinese | |
| 关于提前赎回药石转债的第十一次提示性公告 | 2025-08-29 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40024662 | 关于提前赎回药石转债的第十五次提示性公告 | 2025-09-04 | Chinese | ||
| 40024654 | 关于提前赎回药石转债的第十四次提示性公告 | 2025-09-03 | Chinese | ||
| 40024647 | 关于提前赎回药石转债的第十三次提示性公告 | 2025-09-02 | Chinese | ||
| 40024644 | 关于提前赎回药石转债的第十二次提示性公告 | 2025-09-01 | Chinese | ||
| 40024632 | 关于药石转债转股数额累计达到转股前公司已发行股份总额10%的公告 | 2025-08-29 | Chinese | ||
| 40024629 | 关于提前赎回药石转债的第十一次提示性公告 | 2025-08-29 | Chinese | ||
| 40024627 | 简式权益变动报告书 | 2025-08-29 | Chinese | ||
| 40024625 | 关于控股股东、实际控制人及其一致行动人股份变动触及5%的整数倍暨披露简式权益变动报告书的提示性公告 | 2025-08-29 | Chinese | ||
| 40024614 | 关于提前赎回药石转债的第十次提示性公告 | 2025-08-28 | Chinese | ||
| 40024597 | 关于提前赎回药石转债的第九次提示性公告 | 2025-08-27 | Chinese | ||
| 40024594 | 关于提前赎回药石转债的第八次提示性公告 | 2025-08-26 | Chinese | ||
| 40024591 | 关于提前赎回药石转债的第七次提示性公告 | 2025-08-25 | Chinese | ||
| 40024583 | 2025年第一次临时股东大会决议公告 | 2025-08-25 | Chinese | ||
| 40024578 | 药石科技2025年第一次临时股东大会法律意见书 | 2025-08-25 | Chinese | ||
| 40024576 | 关于选举公司职工代表董事的公告 | 2025-08-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.